Risk factors for hepatic veno-occlusive disease: a retrospective unicentric study in 116 children autografted after a high-dose BU-thiotepa regimen.
about
Autologous hematopoietic stem cell transplantation following high-dose chemotherapy for non-rhabdomyosarcoma soft tissue sarcomasAdvancements in the treatment of pediatric acute leukemia and brain tumor - continuous efforts for 100% cureEmergent Complications in the Pediatric Hematopoietic Stem Cell Transplant PatientPrimary central nervous system lymphoma: implication of high-dose chemotherapy followed by auto-SCTHepatic veno-occlusive disease in children after hematopoietic stem cell transplantation: incidence, risk factors, and outcome.Weight-based strategy of dose administration in children using intravenous busulfan: clinical and pharmacokinetic results.High-dose busulfan-thiotepa with autologous stem cell transplantation followed by posterior fossa irradiation in young children with classical or incompletely resected medulloblastoma.Infusion of endothelial progenitor cells ameliorates liver injury in mice after haematopoietic stem cell transplantation.Iron Overload Exacerbates Busulfan-Melphalan Toxicity Through a Pharmacodynamic Interaction in Mice.High pre-transplant serum ferritin and busulfan-thiotepa conditioning regimen as risk factors for hepatic sinusoidal obstructive syndrome after autologous stem cell transplantation in patients with malignant lymphoma.Risk factors for hepatic veno-occlusive disease caused by Gynura segetum: a retrospective study
P2860
Q24234049-24281432-BD71-4E62-926D-53A126E796A4Q27027799-117A1C6D-323C-46B6-BCB8-B985142DBE3DQ34522746-6E25B5A9-838C-4804-BFC5-884268EEF25FQ37946249-8CB2DC48-1A81-4C08-B1B7-8E28E138D993Q43221658-017F25E7-E3B3-470B-87CA-A4B1DBE29740Q47395006-F8F6B163-6E97-4965-A5C8-3F10B1BE946DQ50728732-523E859C-57DC-44CF-AA0F-87580A1741DDQ50989392-416BE9F4-9228-4AB8-BF01-FCB8FB55997EQ52874377-744DDD63-12ED-4BC9-AA3D-5E5D8F5D8AD2Q52949564-3F60CC0A-DA27-428F-9EED-B2AC80662E47Q58112904-1F98A982-51AC-4E6B-98A1-FBA88DB53507
P2860
Risk factors for hepatic veno-occlusive disease: a retrospective unicentric study in 116 children autografted after a high-dose BU-thiotepa regimen.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Risk factors for hepatic veno- ...... high-dose BU-thiotepa regimen.
@en
Risk factors for hepatic veno- ...... high-dose BU-thiotepa regimen.
@nl
type
label
Risk factors for hepatic veno- ...... high-dose BU-thiotepa regimen.
@en
Risk factors for hepatic veno- ...... high-dose BU-thiotepa regimen.
@nl
prefLabel
Risk factors for hepatic veno- ...... high-dose BU-thiotepa regimen.
@en
Risk factors for hepatic veno- ...... high-dose BU-thiotepa regimen.
@nl
P2093
P2860
P356
P1476
Risk factors for hepatic veno- ...... high-dose BU-thiotepa regimen
@en
P2093
A LeMaitre
D Valteau Couanet
E Benhamou
N Simonnard
O Hartmann
P2860
P2888
P304
P356
10.1038/BMT.2008.186
P407
P577
2008-06-30T00:00:00Z